Role of adenosine and P2 receptors in the penile tumescence in anesthetized dogs

被引:31
|
作者
Noto, T [1 ]
Inoue, H [1 ]
Mochida, H [1 ]
Kikkawa, K [1 ]
机构
[1] Tanabe Seiyaku Co Ltd, Discovery Lab, Toda, Saitama 3358505, Japan
关键词
ATP; pelvic nerve; T-1032;
D O I
10.1016/S0014-2999(01)01167-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We studied the role of adenosine and P2 receptors in the pelvic nerve stimulation-induced penile tumescence in anesthetized dogs. A local intracavernous injection of adenosine induced the tumescence, which was abolished by intracavernous 8-(p-sulfophenyl)theophylline (8-SPT), an unspecific adenosine receptor antagonist, and by 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-yl amino]ethyl)phenol (ZM241385), an adenosine A(2A) receptor antagonist. ATP also induced the tumescence, which was diminished by 8-SPT, but not by reactive blue-2, a P2 receptor antagonist. Neither intracavernous beta, gamma -meATP nor ADP(beta)S, P2X and P2Y receptor agonists, induced tumescence. N-G-nitro-L-arginine (L-NAME), a nitric oxide synthase inhibitor, and T-1032, a phosphodiesterase type V inhibitor, had no effects on the tumescence induced by adenosine. S-SPT and reactive blue-2 had no effects on the tumescence induced by pelvic nerve stimulation. These results show that although exogenous adenosine and ATP induce tumescence, neither the adenosine nor the P2 receptor is involved in the tumescence induced by pelvic nerve stimulation in anesthetized dogs. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:51 / 55
页数:5
相关论文
共 50 条
  • [41] Activation of P2 nucleotide receptors stimulates acid efflux from astrocytes
    Dixon, SJ
    Yu, RG
    Panupinthu, N
    Wilson, JX
    GLIA, 2004, 47 (04) : 367 - 376
  • [42] Interaction of medullary P2 and glutamate receptors mediates the vasodilation in the hindlimb of rat
    Korim, Willian Seiji
    Ferreira-Neto, Marcos L.
    Pedrino, Gustavo R.
    Pilowsky, Paul M.
    Cravo, Sergio L.
    PURINERGIC SIGNALLING, 2012, 8 (04) : 715 - 728
  • [43] Shaping immune responses through the activation of dendritic cells' P2 receptors
    Ferrari, Davide
    Gorini, Stefania
    Callegari, Giulia
    la Sala, Andrea
    PURINERGIC SIGNALLING, 2007, 3 (1-2) : 99 - 107
  • [44] ATP drives eosinophil effector responses through P2 purinergic receptors
    Kobayashi, Takehito
    Soma, Tomoyuki
    Noguchi, Toru
    Nakagome, Kazuyuki
    Nakamoto, Hidetomo
    Kita, Hirohito
    Nagata, Makoto
    ALLERGOLOGY INTERNATIONAL, 2015, 64 : S30 - S36
  • [45] Pharmacological and molecular characterization of functional P2 receptors in rat embryonic cardiomyocytes
    Kwok-Kuen Cheung
    Camila Marques-da-Silva
    Leandro Vairo
    Danúbia Silva dos Santos
    Regina Goldenberg
    Robson Coutinho-Silva
    Geoffrey Burnstock
    Purinergic Signalling, 2015, 11 : 127 - 138
  • [46] Medicinal chemistry of adenosine, P2Y and P2X receptors
    Jacobson, Kenneth A.
    Mueller, Christa E.
    NEUROPHARMACOLOGY, 2016, 104 : 31 - 49
  • [47] Interaction of medullary P2 and glutamate receptors mediates the vasodilation in the hindlimb of rat
    Willian Seiji Korim
    Marcos L. Ferreira-Neto
    Gustavo R. Pedrino
    Paul M. Pilowsky
    Sergio L. Cravo
    Purinergic Signalling, 2012, 8 : 715 - 728
  • [48] Pharmacological and molecular characterization of functional P2 receptors in rat embryonic cardiomyocytes
    Cheung, Kwok-Kuen
    Marques-da-Silva, Camila
    Vairo, Leandro
    dos Santos, Danubia Silva
    Goldenberg, Regina
    Coutinho-Silva, Robson
    Burnstock, Geoffrey
    PURINERGIC SIGNALLING, 2015, 11 (01) : 127 - 138
  • [49] Shaping immune responses through the activation of dendritic cells–P2 receptors
    Davide Ferrari
    Stefania Gorini
    Giulia Callegari
    Andrea la Sala
    Purinergic Signalling, 2007, 3 : 99 - 107
  • [50] Apoptosis induced by extracellular ATP in the mouse neuroblastoma cell line N1E-115: studies on involvement of P2 receptors and adenosine
    Schrier, SM
    Florea, BI
    Mulder, GJ
    Nagelkerke, JF
    IJzerman, AP
    BIOCHEMICAL PHARMACOLOGY, 2002, 63 (06) : 1119 - 1126